Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Homoallylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112010910B details a novel iridium-catalyzed synthesis of chiral ferrocene homoallylamines, offering high yields and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Novel iridium-catalyzed synthesis offers high enantioselectivity for pharmaceutical intermediates. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel photocatalyst-free method for high-purity homoallylamine intermediates using water and visible light, ensuring cost-effective and scalable manufacturing.
Novel visible light method reduces metal waste. Enhances supply chain stability for high-purity pharmaceutical intermediates. Cost-effective scalable production.
Solve N-aryl imine allylation challenges with this metal-free, air-tolerant process. Achieve 94% yields and eliminate expensive anhydrous equipment. Contact for CDMO scale-up.
Solve N-aryl imine allylation challenges with this metal-free, air-stable method. Achieve 85-94% yields at room temperature, reducing equipment costs and supply chain risks for API synthesis.